Feb 28 |
Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Xencor, Inc. (XNCR) Q4 2023 Earnings Call Transcript
|
Feb 27 |
Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates
|
Feb 27 |
Xencor Inc (XNCR) Reports Mixed Financial Results for Q4 and Full Year 2023
|
Feb 27 |
Xencor GAAP EPS of -$0.31 misses by $0.32, revenue of $44.7M misses by $30.01M
|
Feb 27 |
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 26 |
Xencor Q4 2023 Earnings Preview
|
Feb 20 |
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
|
Feb 19 |
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
|
Feb 15 |
Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release
|